title: Advantages and limitations of clopidogrel response testing methods.
authors.affiliation: Medical Academy, US Medical School, European University, Belgrade, Serbia.
authors.forename: Nina
authors.initials: N
authors.lastname: Djukanović
authors.forename: Zoran
authors.initials: Z
authors.lastname: Todorović
authors.forename: Srdjana
authors.initials: S
authors.lastname: Njegomirović
authors.forename: Miodrag
authors.initials: M
authors.lastname: Ostojić
authors.forename: Milica
authors.initials: M
authors.lastname: Prostran
mesh_terms: D000077144:Clopidogrel; D016903:Drug Monitoring; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D010979:Platelet Function Tests; D058912:Purinergic P2Y Receptor Agonists / Q000627:therapeutic use*; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D010975:Platelet Aggregation Inhibitors; D058912:Purinergic P2Y Receptor Agonists; D000077144:Clopidogrel; D013988:Ticlopidine